| Fiscal Q1 Ending 12/12 |
Fiscal Q4 Ending 09/12 |
Fiscal Q3 Ending 06/12 |
Fiscal Q2 Ending 03/12 |
Fiscal Q1 Ending 12/11 |
|
Sales/Revenue |
11,341,000 | 10,782,000 | 11,088,000 | 9,629,000 | 10,779,000 |
Cost of Goods Sold (COGS) incl. D&A |
9,201,000 | 8,612,000 | 8,264,000 | 7,837,000 | 8,641,000 |
COGS excluding D&A |
8,687,000 | 8,120,000 | 7,742,000 | 7,349,000 | 8,156,000 |
Depreciation & Amortization Expense |
514,000 | 492,000 | 522,000 | 488,000 | 485,000 |
Gross Income |
2,140,000 | 2,170,000 | 2,824,000 | 1,792,000 | 2,138,000 |
SG&A Expense |
0 | 0 | 0 | 0 | 0 |
Research & Development |
0 | 0 | 0 | 0 | 0 |
Other SG&A |
0 | 0 | 0 | 0 | 0 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
321,000 | 4,000 | 1,000 | -146,000 | 6,000 |
Non Operating Income/Expense |
87,000 | -136,000 | 130,000 | -105,000 | 54,000 |
Equity in Affiliates (Pretax) |
110,000 | 175,000 | 169,000 | 138,000 | 145,000 |
Interest Expense |
8,000 | 115,000 | 115,000 | 126,000 | 116,000 |
Gross Interest Expense |
22,000 | 136,000 | 140,000 | 126,000 | 116,000 |
Pretax Income |
2,028,000 | 2,114,000 | 3,029,000 | 1,876,000 | 2,241,000 |
Income Tax |
590,000 | 724,000 | 993,000 | 650,000 | 720,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
1,438,000 | 1,390,000 | 2,036,000 | 1,226,000 | 1,521,000 |
Minority Interest Expense |
56,000 | 146,000 | 205,000 | 83,000 | 57,000 |
Net Income |
1,382,000 | 1,244,000 | 1,831,000 | 1,143,000 | 1,464,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
1,382,000 | 1,244,000 | 1,831,000 | 1,143,000 | 1,464,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
1,382,000 | 1,244,000 | 1,831,000 | 1,143,000 | 1,464,000 |
Operational EPS |
0.89 | 0.69 | 1.01 | 0.57 | 0.80 |
EPS (basic) |
0.78 | 0.69 | 1.02 | 0.64 | 0.81 |
EBITDA |
2,654,000 | 2,662,000 | 3,346,000 | 2,280,000 | 2,623,000 |
Depreciation & Amortization Expense |
514,000 | 492,000 | 522,000 | 488,000 | 485,000 |
Common Shares Outstanding |
1,800,000 | 1,818,000 | 1,812,000 | 1,818,000 | 1,824,000 |
Basic Shares Outstanding |
1,777,000 | 1,794,000 | 1,791,000 | 1,793,000 | 1,798,000 |
Diluted Shares Outstanding |
1,800,000 | 1,818,000 | 1,812,000 | 1,818,000 | 1,824,000 |
Diluted EPS after Extraordinary Items |
0.77 | 0.68 | 1.01 | 0.63 | 0.80 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
0.78 | 0.69 | 1.02 | 0.64 | 0.81 |
*Figures in thousands of U.S. Dollars except shares outstanding.
